Immunoassay Market Growth Trajectory – Insights On Key Drivers, Major Trends, And Top Opportunities
31 May, 2023
The global immunoassay market size is expected to grow from $32.76 billion in 2022 to $34.45 billion in 2023 at a compound annual growth rate (CAGR) of 5.16%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global immunoassay market size is expected to reach $42.09 billion in 2027 at a CAGR of 5.13%.
Global Immunoassay Market Key Driver
The rising prevalence of infectious and chronic diseases is likely to drive the immunoassay industry forward in the next years. Chronic illnesses are defined as those that last a year or longer, necessitate ongoing medical treatment, limit daily activities, or both. Infectious diseases are those caused by organisms like bacteria, viruses, fungus, or parasites. Many species reside and live on the human body. A variety of infectious diseases can be passed from person to person. Immunoassay is used to detect a variety of infectious and chronic disorders.
Get a sample of the global immunoassay market reportGlobal Immunoassay Market Segments
The global immunoassay market is segmented:
1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End User: Research And Academic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies And CROs, Blood Banks, Hospitals And Clinics, Clinical Laboratories
5) By Geography: The regions covered in the immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global immunoassay market.
Major Immunoassay Industry Players
Siemens Healthineers GmbH, bioMérieux, Abbott, Beckman Coulter Inc., Quidel Corporation, Ortho Clinical Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., BD, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc, WAK-Chemie Medical GmbH, J Mitra & Co Pvt Ltd, Kamiya Biomedical Company, Tosoh Corporation, Gyros Protein Technologies AB, BioCheck Inc., Bio-Techne, DiaSorin S.p.A, Meso Scale Diagnostics LLC, QIAGEN, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd
Get the full global immunoassay market report
Immunoassay Market Overview
Immunoassay is a bioanalytical test that employs antibody attachment to antigens to detect and quantify specific chemicals. Diseases can be diagnosed using immunoassays. Furthermore, information from test findings concerning an illness may be used to establish a course of therapy. This technique relies primarily on a competitive binding response for a finite number of receptors on an extremely specific anti-analyte antibody between a set quantity of labelled versions of an analyte and a substantial portion of an unmarked sample analyte.
Immunoassay Global Market Report 2023 provides data on the global immunoassay market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The immunoassay market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.